SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medi-Caps informs about updates

24 May 2025 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in furtherance to intimation dated 24th February,2025, Medi-Caps has informed that the United States Food & Drug Administration (USFDA) conducted an inspection at the manufacturing facility of Wholly Owned Subsidiary Company, Medgel at Pithampur, Madhya Pradesh, from 17th to 21st February, 2025 and it has informed that the company has received a communication from US FDA indicating that the inspection classification of this facility as ‘Voluntary Action Indicated’ (VAI). FDA has concluded that this inspection is ‘closed’ under 21 CFR 20.64 (d) (3). The above information will also be available on the website of the Company at www.medicaps.com.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

29.34 -0.18 (-0.61%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3739.05
Tata Chemicals 707.80
SRF 2541.95
Pidilite Inds. 1402.25
Deepak Nitrite 1731.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×